Table 2.
BV/TV (%)/week | Tb.N. (mm−1/week) | Tb.Th. (mm/week) | Tb.Sep. (mm/week) | |||||
---|---|---|---|---|---|---|---|---|
OVX | Sham | OVX | Sham | OVX | Sham | OVX | Sham | |
Line C | −4.4 LS1 (0.34) | −2.3 (0.52) | −0.49LS2 (0.03) | −0.30LS2 (0.06) | −0.002 LS1 (0.0004) | 0 LS1,LS2 (0.0005) | 0.031 (0.004) | 0.020 (0.0069) |
Line 1 | −1.9C (0.72) | −1.4 (0.35) | −0.33 (0.08) | −0.36LS2 (0.06) | 0.001C, LS2 (0.0006) | 0.002C (0.0003) | 0.031 (0.0081) | 0.033 (0.0069) |
Line 2 | −2.7 (0.38) | −1.2 (0.21) | −0.21C (0.03) | −0.09C,LS1 (0.03) | −0.001 C, LS1 (0.0004) | 0.002 C (0.0002) | 0.040 (0.0082) | 0.024 (0.0111) |
Within treatments (columns, OVX vs Sham), superscripts denote significant differences in means (p < 0.05) between a given group and: CLine C, LS1Line 1, LS2Line 2. Within lines (rows), italicized values indicate significant differences in mean rates (p < 0.05) between treatments.